Items where authors include "Cunningham, D."

Article

Grosser, B., Emmerson, J. orcid.org/0000-0002-8198-8043, Reitsam, N.G. orcid.org/0000-0002-0070-3158 et al. (7 more authors) (2024) Stroma AReactive Invasion Front Areas (SARIFA) improves prognostic risk stratification of perioperative chemotherapy treated oesophagogastric cancer patients from the MAGIC and the ST03 trial. British Journal of Cancer, 130 (3). pp. 457-466. ISSN 0007-0920

Ng, K.W., Boumelha, J., Enfield, K.S.S. orcid.org/0000-0002-4551-6073 et al. (328 more authors) (2023) Antibodies against endogenous retroviruses promote lung cancer immunotherapy. Nature, 616. pp. 563-573. ISSN 0028-0836

Beuque, M., Magee, D.R. orcid.org/0000-0003-2170-3103, Chatterjee, A. et al. (7 more authors) (2023) Automated detection and delineation of lymph nodes in haematoxylin & eosin stained digitised slides. Journal of Pathology Informatics, 14. 100192. ISSN 2229-5089

Murphy, L.A., Akehurst, R., Solà-Morales, O. et al. (4 more authors) (2023) Structure and content of a taxonomy to support the use of real-world evidence by health technology assessment practitioners and healthcare decision makers. Value in Health. ISSN 1098-3015

Murphy, L.A., Akehurst, R., Solà-Morales, O. et al. (4 more authors) (2023) The real-world evidence workstream In EUreccA 2025: how the task was addressed. Value in Health. ISSN 1098-3015

Smyth, E.C., Cafferkey, C., Loehr, A. et al. (17 more authors) (2018) Genomic loss of heterozygosity and survival in the REAL3 trial. Oncotarget, 9 (94). pp. 36654-36665. ISSN 1949-2553

Gleeson, M., Peckitt, C., To, Y.M. et al. (25 more authors) (2018) CHOP versus GEM-P in previously untreated patients with peripheral T-cell lymphoma (CHEMO-T): a phase 2, multicentre, randomised, open-label trial. Lancet Haematology , 5 (5). e190-e200. ISSN 2352-3026

Neoptolemos, J.P., Palmer, D.H., Ghaneh, P. et al. (32 more authors) (2017) Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial. Lancet, 389 (10073). pp. 1011-1024. ISSN 0140-6736

Cunningham, D., Stenning, S.P., Smyth, E.C. et al. (15 more authors) (2017) Peri-operative chemotherapy with or without bevacizumab in operable oesophagogastric adenocarcinoma (UK Medical Research Council ST03): primary analysis results of a multicentre, open-label, randomised phase 2–3 trial. The Lancet Oncology, 18 (3). pp. 357-370. ISSN 1470-2045

Baird, R., Banks, I., Cameron, D. et al. (53 more authors) (2016) An Association of Cancer Physicians' strategy for improving services and outcomes for cancer patients. Ecancermedicalscience, 10. p. 608.

Su, Z., Gay, L.J., Strange, A. et al. (143 more authors) (2012) Common variants at the MHC locus and at chromosome 16q24.1 predispose to Barrett's esophagus. Nature Genetics, 44 (10). pp. 1131-1136. ISSN 1061-4036

Burton, C., Linch, D., Hoskin, P. et al. (10 more authors) (2006) A phase III trial comparing CHOP to PMitCEBO with or without G-CSF in patients aged 60 plus with aggressive non-Hodgkin's lymphoma. British Journal of Cancer, 94 (6). pp. 806-813. ISSN 0007-0920

Burton, C., Smith, P., Vaughan-Hudson, G. et al. (5 more authors) (2005) Comparison of CHOP versus CIOP in good prognosis younger patients with histologically aggressive non-Hodgkin lymphoma. British Journal of Haematology, 130 (4). pp. 536-541. ISSN 0007-1048